NBSE - NeuBase Therapeutics Inc
Close
0.378
-0.013 -3.307%
Share volume: 97,744
Last Updated: Fri 10 May 2024 10:00:00 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.39
-0.01
-3.20%
Summary score
49%
Profitability
50%
Dept financing
3%
Liquidity
46%
Performance
60%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 31-Dec-2015 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-40.27%
Return on assets
-29.17%
Return on sales
0%
Return on invested capital
169%
Total debt ratio
14.04%
Debt ratio change over timeo
-1.38%
Current Ratio
3.63%
Quick Ratio
0%
Cash Position Ratio
3.54%
Short-term ratios 31-Dec-2018 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-82.05%
Return on assets
-62.99%
Return on sales
0%
Return on invested capital
887.04%
Total debt ratio
15.99%
Debt ratio change over timeo
-1.33%
Current Ratio
3.71%
Quick Ratio
0%
Cash Position Ratio
3.41%
Last quarter ratios 31-Dec-2019
The data are presented for the financials results of the last quarter.
Return on equity
-64.11%
Return on assets
-38.29%
Return on sales
0%
Return on invested capital
299.42%
Total debt ratio
28.85%
Debt ratio change over time
-0.99%
Current Ratio
2.99%
Quick Ratio
0%
Cash Position Ratio
2.71%
Performance ratios (change over 4 years) 31-Dec-2015 - 31-Dec-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
48.95%
Return on assets
-48.17%
Return on sales
0%
Return on invested capital
156.19%
Total debt ratio
-138.39%
Debt ratio change over time
-1.38%
Current Ratio
-21.1%
Quick Ratio
0%
Cash Position Ratio
-22.41%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NBSE | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -40.27% | 0% | 0% | 36.82% |
| Return on assets | -29.17% | 0% | 0% | -9.86% |
| Return on sales | 0% | 0% | 0% | -1059.83% |
| Return on invested capital | 169% | 0% | 0% | 39.06% |
| Profitability | 50% | 0% | 25% | 31% |
| Total debt ratio | 14.04% | 0% | 0% | 200.03% |
| Debt ratio change over time | -1.38% | 0% | 0% | 22.04% |
| Dept financing | 2% | 0% | 0% | 50% |
| Current Ratio | 3.71% | 0% | 0% | 4.06% |
| Quick Ratio | 0% | 0% | 0% | 4.06% |
| Cash Position Ratio | 3.41% | 0% | 0% | 3.98% |
| Liquididy | 50% | 0% | 0% | 71% |
| Short-term ratios | NBSE | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -82.05% | 0% | 0% | 180.3% |
| Return on assets | -62.99% | 0% | 0% | -15.43% |
| Return on sales | 0% | 0% | 0% | -2041.9% |
| Return on invested capital | 887.04% | 0% | 0% | 73.31% |
| Profitability | 50% | 0% | 25% | 27% |
| Total debt ratio | 15.99% | 0% | 0% | 100.23% |
| Debt ratio change over time | -1.33% | 0% | 0% | 0.74% |
| Dept financing | 4% | 0% | 0% | 50% |
| Current Ratio | 3.71% | 0% | 0% | 4.06% |
| Quick Ratio | 0% | 0% | 0% | 4.06% |
| Cash Position Ratio | 3.41% | 0% | 0% | 3.98% |
| Liquididy | 44% | 0% | 0% | 75% |